Gastric inhibitory polypeptide (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Gastric inhibitory polypeptide" in English language version.

refsWebsite

Global rank English rank

16nih.gov

4^th place

10doi.org

2^nd place

5semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1web.archive.org

1^st place

1uthm.edu.my

low place

1univ-angers.fr

low place

doi.org

Meier JJ, Nauck MA (2005). "Glucagon-like peptide 1(GLP-1) in biology and pathology". Diabetes/Metabolism Research and Reviews. 21 (2): 91–117. doi:10.1002/dmrr.538. PMID 15759282. S2CID 39547553.
Pederson RA, McIntosh CH (April 2016). "Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections". Journal of Diabetes Investigation. 7 (Suppl 1): 4–7. doi:10.1111/jdi.12480. PMC 4854497. PMID 27186348.
Efendic S, Portwood N (2004). "Overview of incretin hormones". Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme. 36 (11–12): 742–746. doi:10.1055/s-2004-826157. PMID 15655702. S2CID 11634548.
Kim W, Egan JM (December 2008). "The role of incretins in glucose homeostasis and diabetes treatment". Pharmacological Reviews. 60 (4): 470–512. doi:10.1124/pr.108.000604. PMC 2696340. PMID 19074620.
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W (1992). "Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects". Digestion. 52 (3–4): 214–221. doi:10.1159/000200956. PMID 1459356.
Seino Y, Fukushima M, Yabe D (April 2010). "GIP and GLP-1, the two incretin hormones: Similarities and differences". Journal of Diabetes Investigation. 1 (1–2): 8–23. doi:10.1111/j.2040-1124.2010.00022.x. PMC 4020673. PMID 24843404.
Gaudin-Audrain C, Irwin N, Mansur S, Flatt PR, Thorens B, Baslé M, et al. (March 2013). "Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice" (PDF). Bone. 53 (1): 221–230. doi:10.1016/j.bone.2012.11.039. PMID 23220186. S2CID 36280105. Archived from the original (PDF) on 2018-07-21. Retrieved 2018-11-20.
Mieczkowska A, Irwin N, Flatt PR, Chappard D, Mabilleau G (October 2013). "Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality" (PDF). Bone. 56 (2): 337–342. doi:10.1016/j.bone.2013.07.003. PMID 23851294. S2CID 19296511.
Skrha J, Hilgertová J, Jarolímková M, Kunešová M, Hill M (2010). "Meal test for glucose-dependent insulinotropic peptide (GIP) in obese and type 2 diabetic patients". Physiological Research. 59 (5): 749–755. doi:10.33549/physiolres.931893. PMID 20406045.
Yamada Y, Seino Y (2004). "Physiology of GIP--a lesson from GIP receptor knockout mice". Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme. 36 (11–12): 771–774. doi:10.1055/s-2004-826162. PMID 15655707. S2CID 262453421.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000159224 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000014351 – Ensembl, May 2017

nih.gov

pubmed.ncbi.nlm.nih.gov

Meier JJ, Nauck MA (2005). "Glucagon-like peptide 1(GLP-1) in biology and pathology". Diabetes/Metabolism Research and Reviews. 21 (2): 91–117. doi:10.1002/dmrr.538. PMID 15759282. S2CID 39547553.
Pederson RA, McIntosh CH (April 2016). "Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections". Journal of Diabetes Investigation. 7 (Suppl 1): 4–7. doi:10.1111/jdi.12480. PMC 4854497. PMID 27186348.
Efendic S, Portwood N (2004). "Overview of incretin hormones". Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme. 36 (11–12): 742–746. doi:10.1055/s-2004-826157. PMID 15655702. S2CID 11634548.
Kim W, Egan JM (December 2008). "The role of incretins in glucose homeostasis and diabetes treatment". Pharmacological Reviews. 60 (4): 470–512. doi:10.1124/pr.108.000604. PMC 2696340. PMID 19074620.
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W (1992). "Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects". Digestion. 52 (3–4): 214–221. doi:10.1159/000200956. PMID 1459356.
Thorens B (December 1995). "Glucagon-like peptide-1 and control of insulin secretion". Diabète & Métabolisme. 21 (5): 311–318. PMID 8586147.
Seino Y, Fukushima M, Yabe D (April 2010). "GIP and GLP-1, the two incretin hormones: Similarities and differences". Journal of Diabetes Investigation. 1 (1–2): 8–23. doi:10.1111/j.2040-1124.2010.00022.x. PMC 4020673. PMID 24843404.
Gaudin-Audrain C, Irwin N, Mansur S, Flatt PR, Thorens B, Baslé M, et al. (March 2013). "Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice" (PDF). Bone. 53 (1): 221–230. doi:10.1016/j.bone.2012.11.039. PMID 23220186. S2CID 36280105. Archived from the original (PDF) on 2018-07-21. Retrieved 2018-11-20.
Mieczkowska A, Irwin N, Flatt PR, Chappard D, Mabilleau G (October 2013). "Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality" (PDF). Bone. 56 (2): 337–342. doi:10.1016/j.bone.2013.07.003. PMID 23851294. S2CID 19296511.
Skrha J, Hilgertová J, Jarolímková M, Kunešová M, Hill M (2010). "Meal test for glucose-dependent insulinotropic peptide (GIP) in obese and type 2 diabetic patients". Physiological Research. 59 (5): 749–755. doi:10.33549/physiolres.931893. PMID 20406045.
Yamada Y, Seino Y (2004). "Physiology of GIP--a lesson from GIP receptor knockout mice". Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme. 36 (11–12): 771–774. doi:10.1055/s-2004-826162. PMID 15655707. S2CID 262453421.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Pederson RA, McIntosh CH (April 2016). "Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections". Journal of Diabetes Investigation. 7 (Suppl 1): 4–7. doi:10.1111/jdi.12480. PMC 4854497. PMID 27186348.
Kim W, Egan JM (December 2008). "The role of incretins in glucose homeostasis and diabetes treatment". Pharmacological Reviews. 60 (4): 470–512. doi:10.1124/pr.108.000604. PMC 2696340. PMID 19074620.
Seino Y, Fukushima M, Yabe D (April 2010). "GIP and GLP-1, the two incretin hormones: Similarities and differences". Journal of Diabetes Investigation. 1 (1–2): 8–23. doi:10.1111/j.2040-1124.2010.00022.x. PMC 4020673. PMID 24843404.

semanticscholar.org

api.semanticscholar.org

Meier JJ, Nauck MA (2005). "Glucagon-like peptide 1(GLP-1) in biology and pathology". Diabetes/Metabolism Research and Reviews. 21 (2): 91–117. doi:10.1002/dmrr.538. PMID 15759282. S2CID 39547553.
Efendic S, Portwood N (2004). "Overview of incretin hormones". Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme. 36 (11–12): 742–746. doi:10.1055/s-2004-826157. PMID 15655702. S2CID 11634548.
Gaudin-Audrain C, Irwin N, Mansur S, Flatt PR, Thorens B, Baslé M, et al. (March 2013). "Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice" (PDF). Bone. 53 (1): 221–230. doi:10.1016/j.bone.2012.11.039. PMID 23220186. S2CID 36280105. Archived from the original (PDF) on 2018-07-21. Retrieved 2018-11-20.
Mieczkowska A, Irwin N, Flatt PR, Chappard D, Mabilleau G (October 2013). "Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality" (PDF). Bone. 56 (2): 337–342. doi:10.1016/j.bone.2013.07.003. PMID 23851294. S2CID 19296511.
Yamada Y, Seino Y (2004). "Physiology of GIP--a lesson from GIP receptor knockout mice". Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme. 36 (11–12): 771–774. doi:10.1055/s-2004-826162. PMID 15655707. S2CID 262453421.

univ-angers.fr

hal.univ-angers.fr

Mieczkowska A, Irwin N, Flatt PR, Chappard D, Mabilleau G (October 2013). "Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality" (PDF). Bone. 56 (2): 337–342. doi:10.1016/j.bone.2013.07.003. PMID 23851294. S2CID 19296511.

uthm.edu.my

eprints.uthm.edu.my

Gaudin-Audrain C, Irwin N, Mansur S, Flatt PR, Thorens B, Baslé M, et al. (March 2013). "Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice" (PDF). Bone. 53 (1): 221–230. doi:10.1016/j.bone.2012.11.039. PMID 23220186. S2CID 36280105. Archived from the original (PDF) on 2018-07-21. Retrieved 2018-11-20.

web.archive.org

Gaudin-Audrain C, Irwin N, Mansur S, Flatt PR, Thorens B, Baslé M, et al. (March 2013). "Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice" (PDF). Bone. 53 (1): 221–230. doi:10.1016/j.bone.2012.11.039. PMID 23220186. S2CID 36280105. Archived from the original (PDF) on 2018-07-21. Retrieved 2018-11-20.